These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16007039)

  • 1. [L-arginin-nitric oxide system in the therapy of diseases of the heart and vessels].
    Markov KhM
    Kardiologiia; 2005; 45(6):87-95. PubMed ID: 16007039
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
    Herbaczyńska-Cedro K
    J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.
    Ahmed LA; Obaid AA; Zaki HF; Agha AM
    Eur J Pharm Sci; 2014 Oct; 62():161-70. PubMed ID: 24878387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine in cardiovascular disease: dream or reality?
    Tousoulis D; Antoniades C; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
    Vasc Med; 2002 Aug; 7(3):203-11. PubMed ID: 12553744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets.
    Siqueira MA; Fischer RG; Pereira NR; Martins MA; Moss MB; Mendes-Ribeiro AC; Figueredo CM; Brunini TM
    Exp Biol Med (Maywood); 2013 Jun; 238(6):713-22. PubMed ID: 23918883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma.
    Mabalirajan U; Ahmad T; Leishangthem GD; Joseph DA; Dinda AK; Agrawal A; Ghosh B
    J Allergy Clin Immunol; 2010 Mar; 125(3):626-35. PubMed ID: 20153031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Play it safe, avoid L-arginine supplements.
    Harv Heart Lett; 2006 Mar; 16(7):6. PubMed ID: 19663031
    [No Abstract]   [Full Text] [Related]  

  • 11. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
    Pernow J; Jung C
    Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
    Chander V; Chopra K
    Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-arginine transporters in cardiovascular disease: a novel therapeutic target.
    Chin-Dusting JP; Willems L; Kaye DM
    Pharmacol Ther; 2007 Dec; 116(3):428-36. PubMed ID: 17915331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine in the management of cardiovascular diseases.
    Cheng JW; Baldwin SN
    Ann Pharmacother; 2001 Jun; 35(6):755-64. PubMed ID: 11408995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology].
    Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG
    Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in cardiovascular disease: successful translation from bench to bedside?
    Schnabel R; Blankenberg S
    Circulation; 2007 Sep; 116(12):1338-40. PubMed ID: 17875978
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.
    Zamora PL; Villamena FA
    Future Med Chem; 2013 Mar; 5(4):465-78. PubMed ID: 23495692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mercury Exposure and Endothelial Dysfunction: An Interplay Between Nitric Oxide and Oxidative Stress.
    Omanwar S; Fahim M
    Int J Toxicol; 2015; 34(4):300-7. PubMed ID: 26060268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases.
    Frombaum M; Le Clanche S; Bonnefont-Rousselot D; Borderie D
    Biochimie; 2012 Feb; 94(2):269-76. PubMed ID: 22133615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.